Senior Manager, Business Insights and Analytics, Central & Eastern Europe at Bristol-Myers Squibb

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

BA/BS degree required; MBA or Masters in a quantitative major or concentration preferred
7+ years of pharmaceutical/related market experience, including working knowledge of various analytical capabilities
Analytical ability to leverage large, multi-dimensional data sets to drive business decisions; strongly recommended: patient-based or patient-flow forecast modeling
Strong written and verbal communication skills; ability to frame issues and present to business stakeholders
Project management ability to directly manage projects of significant scale or indirectly influence stakeholders to successful conclusion
Required: Working knowledge of Microsoft Excel and PowerPoint, independently and without assistance
Strongly recommended: Proficiency with analytics/data tools such as Power BI, Tableau, Python, R, SQL, etc

Responsibilities

Advises Commercial Leadership Team on decision-making using advanced analytics, business performance reporting, and forecasting for Central & Eastern Europe (Poland, Romania, Greece, Czech Republic, Hungary)
Collaborates with global/regional/cluster Analytics teams and Market Research to answer business questions and support integrated insights plan development
Designs and implements analytics, performance management reporting, and forecasting for planned and ad-hoc needs
Builds relationships with and influences senior management stakeholders (Country Managers, Business Unit Directors, Medical Directors, Strategy & Operations Directors, Finance Directors, etc.)
Synthesizes data from multiple sources to develop realistic, insightful, and actionable recommendations
Applies global standards, models, and templates to drive high quality and consistency in analytics
Presents results of strategic projects (e.g., Forecasts, Resource Allocations, Key Driver Analysis) in a coherent and meaningful way
Provides leadership in quarterly Projection process and annual Market Planning & Budgeting process
Proactively manages flow of planned and ad-hoc requests to internal and external resources
Identifies relevant data sources and coordinates acquisition with appropriate functions
Contributes to development and deployment of innovative analytical approaches, therapeutic area learnings, and best practices within global Analytics structure
Liaises with global, other geography, and functional teams for efficient sharing and strategic adoption of learnings and capabilities
May lead third-party contractors

Skills

Advanced Analytics

Business Performance Reporting

Forecasting

Data Synthesis

Performance Management

Stakeholder Management

Strategic Insights

Analytics Implementation

Market Research

Integrated Insights Planning

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free